Condition
End-Tidal Carbon Dioxide
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Enrolling By Invitation1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07506889Not Yet Recruiting
Simplified Exercise-based Risk Assessment in Lung Cancer
NCT07326449Enrolling By Invitation
Test-Retest Reliability And Validation For End-Tidal Carbon Dioxide Measurement (PetCO2) During Rest And Low-Loaded Steady State Work Using A Portable Capnograph.
NCT05778968Not ApplicableCompleted
Etco2 Levels on the End-tidal Concentration of Sevoflurane
NCT05746949Not ApplicableCompleted
Comparison of the Effects of High-flow Nasal Cannula Oxygen and Jet Ventilation Techniques
NCT04281589Not ApplicableCompleted
End-tidal Carbon Dioxide Monitoring in Low Tidal Volume Ventilation
Showing all 5 trials